Orthocell Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Stock Symbol
  • OCC

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.37
  • (As of Tuesday Closing)

Orthocell General Information

Description

Orthocell Ltd is engaged in the development, manufacture and commercialisation of collagen-based medical devices and cell therapies for the repair and regeneration of bone, nerve, tendon and cartilage defects. It has one segment regenerative medicine industry in Australia with products sold in Australia and internationally. Its solutions are Remplier, Striate, and Cell Therapies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 191 Murdoch University
  • South Street
  • Murdoch, Western Australia 6150
  • Australia
+61 (08)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Corporate Office
  • Building 191 Murdoch University
  • South Street
  • Murdoch, Western Australia 6150
  • Australia
+61 (08)

Orthocell Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthocell Stock Performance

As of 17-Nov-2026, Orthocell’s stock price is $0.37. Its current market cap is $102M with 272M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.37 $0.39 $0.34 - $0.80 $102M 272M 381K

Orthocell Financials Summary

As of 30-Sep-2026, Orthocell has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 115,589 105,655 167,050 36,874
Revenue 7,728 4,885 3,483
EBITDA (10,172) (7,215) (6,327)
Net Income (9,426) (5,543) (4,706)
Total Assets 37,718 23,016 17,790
Total Debt 668 377 461
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Orthocell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orthocell‘s full profile, request access.

Request a free trial

Orthocell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Orthocell Ltd is engaged in the development, manufacture and commercialisation of collagen-based medical devices and cel
Drug Discovery
Murdoch, Australia

Canton, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orthocell Competitors (4)

One of Orthocell’s 4 competitors is Organogenesis Holdings, a Pending Transaction (M&A) company based in Canton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organogenesis Holdings Pending Transaction (M&A) Canton, MA
Taxus Cardium Pharmaceuticals Group Formerly VC-backed San Diego, CA
Mimedx Group Corporation Marietta, GA
Sofregen Venture Capital-Backed Framingham, MA
To view Orthocell’s complete competitors history, request access »

Orthocell Patents

Orthocell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022406427-A1 Cellular composition and uses thereof Pending 06-Dec-2021
CA-3240318-A1 Cellular composition and uses thereof Pending 06-Dec-2021
EP-4444868-A1 Cellular composition and uses thereof Pending 06-Dec-2021
EP-4444868-A4 Cellular composition and uses thereof Pending 06-Dec-2021
US-20230174943-A1 Cellular composition and uses thereof Pending 06-Dec-2021 C12N5/066
To view Orthocell’s complete patent history, request access »

Orthocell Investments (2)

Orthocell’s most recent deal was a Corporate with Marine Biomedical for . The deal was made on 16-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Marine Biomedical 16-Jan-2026 Corporate Therapeutic Devices
The University of Western Australia (Ortho ATI Intellectual Property) 12-May-2014 Corporate Asset Purchase Buildings and Property
To view Orthocell’s complete investments history, request access »

Orthocell ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Orthocell’s complete esg history, request access »

Orthocell FAQs

  • When was Orthocell founded?

    Orthocell was founded in 2006.

  • Where is Orthocell headquartered?

    Orthocell is headquartered in Murdoch, Australia.

  • What industry is Orthocell in?

    Orthocell’s primary industry is Drug Discovery.

  • Is Orthocell a private or public company?

    Orthocell is a Public company.

  • What is Orthocell’s stock symbol?

    The ticker symbol for Orthocell is OCC.

  • What is the current stock price of Orthocell?

    As of 17-Nov-2026 the stock price of Orthocell is $0.37.

  • What is the current market cap of Orthocell?

    The current market capitalization of Orthocell is $102M.

  • Who are Orthocell’s competitors?

    Organogenesis Holdings, Taxus Cardium Pharmaceuticals Group, Mimedx Group, and Sofregen are competitors of Orthocell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process